HSPA5 and glioblastoma: However, when repressing GRP78 in drug sensitivity analyses with colony survival assays, GBM cells are notably more sensitive to TMZ and multiple other chemotherapeutic agents including 5-FU, irinotecan, etoposide, and cisplatin (10, 11).